Haleon
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 2022-01-01
- Employees
- 25.4K
- Market Cap
- -
- Website
- http://www.haleon.com
- Introduction
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.
Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: CAP Herbal MintDrug: SPF Standard SunscreenDrug: CAP UnScentedDrug: CAP Mountain Berry
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- HALEON
- Target Recruit Count
- 15
- Registration Number
- NCT05124899
- Locations
- πΊπΈ
GSK Investigational Site, Winston-Salem, North Carolina, United States
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: CAP UnScentedDrug: CAP Herbal MintDrug: CAP Mountain BerryDrug: SPF Standard Sunscreen
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- HALEON
- Target Recruit Count
- 13
- Registration Number
- NCT05109104
- Locations
- πΊπΈ
GSK Investigational Site, Winston-Salem, North Carolina, United States
Clinical Study to Evaluate the Efficacy of an Over-the-counter (OTC) Sunscreen Lip Balm Product
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: CAP Unscented
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- HALEON
- Target Recruit Count
- 39
- Registration Number
- NCT05109117
- Locations
- πΊπΈ
GSK Investigational Site, Piscataway, New Jersey, United States
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Sunscreen Products
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: ChapStick Lip Moisturizer OriginalDrug: ChapStick Lip Moisturizer MintDrug: ChapStick Lip Moisturizer Black CherryDrug: SPF Standard Sunscreen
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- HALEON
- Target Recruit Count
- 11
- Registration Number
- NCT05085327
- Locations
- πΊπΈ
GSK Investigational Site, Winston-Salem, North Carolina, United States
Clinical Study to Evaluate the Efficacy of an Over-the-counter (OTC) Sunscreen Lip Balm
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: CLM Original
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- HALEON
- Target Recruit Count
- 38
- Registration Number
- NCT05082376
- Locations
- πΊπΈ
GSK Investigational Site, Piscataway, New Jersey, United States
A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers
Phase 1
Completed
- Conditions
- Tobacco Use Disorder
- Interventions
- Drug: NicoDerm CQ (Alza)Drug: NicoDerm CQ patch (GSK Dungarvan)
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- HALEON
- Target Recruit Count
- 22
- Registration Number
- NCT05024747
- Locations
- πΊπΈ
GSK Investigational Site, Springfield, Missouri, United States
A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Pain
- Interventions
- Drug: New Paracetamol Oral Suspension (24 mg/ml)
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- HALEON
- Target Recruit Count
- 61
- Registration Number
- NCT05022810
- Locations
- π¨πΏ
GSK Investigational Site, Prague 10, Czechia
A Real-World Evidence Study to Evaluate Oral Health Related Quality of Life Using an Anti-Sensitivity Toothpaste
Not Applicable
Completed
- Conditions
- Dentin Sensitivity
- Interventions
- Other: Potassium Nitrate + Sodium Fluoride
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- HALEON
- Target Recruit Count
- 655
- Registration Number
- NCT04964063
- Locations
- πΊπΈ
GSK Investigational Site, Orlando, Florida, United States
A Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Dentifrice in the Relief of Dentinal Hypersensitivity in a Chinese Population
Not Applicable
Completed
- Conditions
- Dentin Sensitivity
- Interventions
- Other: Sensodyne Sensitivity & GumOther: Sensodyne Repair and ProtectOther: Crest Cavity Protection Fresh Lime
- First Posted Date
- 2021-07-06
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- HALEON
- Target Recruit Count
- 271
- Registration Number
- NCT04950465
- Locations
- π¨π³
GSK Investigational Site, Shanghai, China
A Clinical Study to Evaluate the Efficacy of a Range of Dental/Denture Products for Improved Oral Health in Partial Denture Wearers
Phase 4
Completed
- Conditions
- Gingivitis
- Interventions
- Device: COREGA Denture Foaming Cleanser
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- HALEON
- Target Recruit Count
- 58
- Registration Number
- NCT04290624
- Locations
- π¬π§
GSK Investigational Site, Bristol, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath